Mannkind reported $2.8M in Interest Expense on Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Adamas Pharmaceuticals ADMS:US 3.5M 28K
Adma Biologics ADMA:US $ 3.3M 0.05M
Biocryst Pharmaceuticals BCRX:US $ 14.12M 0.62M
Chemocentryx CCXI:US $ 0.67M 0.03M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Eli Lilly And LLY:US $ 83.6M 3.3M
Flexion Therapeutics FLXN:US $ 6.29M 1.11M
Halozyme Therapeutics HALO:US $ 1.75M 0M
Immunogen IMGN:US $ 2.75M 0.83M
Insmed INSM:US $ 11.24M 926K
JAZZ PHA JAZZ:US $ 93.47M 23.65M
Karyopharm Therapeutics KPTI:US $ 8.01M 3.01M
Mannkind MNKD:US $ 2.8M 0.38M
Novavax NVAX:US $ 5.18M 0.79M
Peregrine Pharmaceuticals PPHM:US 704K 1000
Pfizer PFE:US $ 325M 9M